Market Overview

Hearing UBS Says Endo Likely to be Sold at $40+/share.

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ENDP

DateFirmActionFromTo
Feb 2017Canaccord GenuityInitiates Coverage OnBuyHold
Jan 2017JP MorganDowngradesOverweightNeutral
Jan 2017CitigroupDowngradesBuyNeutral

View More Analyst Ratings for ENDP
View the Latest Analyst Ratings

Posted-In: UBSAnalyst Color News Rumors M&A Analyst Ratings Movers

 

Related Articles (ENDP)